Listed

Co-Diagnostics, Inc.

CODXNasdaqCIK 1692415HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$166.1k, Q2 FY2026
Operating income−$6.2m, Q2 FY2026
Net income−$6.3m, Q2 FY2026
Co-Diagnostics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m2.5Revenue, Q3 FY2023, three months to 2023-09-30$2.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0001493152-24-044008.Report this figure3.6Revenue, Q4 FY2023, three months to 2023-12-31$3.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-27, accession 0001641172-25-000932. Derived: 12-month figure less the 9-month figure.Report this figure0.5Revenue, Q1 FY2024, three months to 2024-03-31$467.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001641172-25-009257.Report this figure2.7Revenue, Q2 FY2024, three months to 2024-06-30$2.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-14, accession 0001641172-25-024029.Report this figure0.6Revenue, Q3 FY2024, three months to 2024-09-30$641.1k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure0.1Revenue, Q4 FY2024, three months to 2024-12-31$149.3k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-014158. Derived: 12-month figure less the 9-month figure.Report this figure0.1Revenue, Q1 FY2025, three months to 2025-03-31$50.3k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure0.2Revenue, Q2 FY2025, three months to 2025-06-30$162.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure0.1Revenue, Q3 FY2025, three months to 2025-09-30$145.4k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure0.3Revenue, Q4 FY2025, three months to 2025-12-31$263.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-014158. Derived: 12-month figure less the 9-month figure.Report this figure0.1Revenue, Q1 FY2026, three months to 2026-03-31$146.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure0.2Revenue, Q2 FY2026, three months to 2026-06-30$166.1k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure
Cost of revenue$m0.3Cost of revenue, Q3 FY2023, three months to 2023-09-30$255.8k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-07, accession 0001493152-24-044008.Report this figure3.0Cost of revenue, Q4 FY2023, three months to 2023-12-31$3.0m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-03-27, accession 0001641172-25-000932. Derived: 12-month figure less the 9-month figure.Report this figure0.2Cost of revenue, Q1 FY2024, three months to 2024-03-31$234.5k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-08, accession 0001641172-25-009257.Report this figure0.2Cost of revenue, Q2 FY2024, three months to 2024-06-30$212.1k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-14, accession 0001641172-25-024029.Report this figure0.3Cost of revenue, Q3 FY2024, three months to 2024-09-30$297.4k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure0.3Cost of revenue, Q4 FY2024, three months to 2024-12-31$255.1k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-31, accession 0001493152-26-014158. Derived: 12-month figure less the 9-month figure.Report this figure0.0Cost of revenue, Q1 FY2025, three months to 2025-03-31$21.6k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure0.0Cost of revenue, Q2 FY2025, three months to 2025-06-30$32.1k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure0.0Cost of revenue, Q3 FY2025, three months to 2025-09-30$26.3k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure0.1Cost of revenue, Q4 FY2025, three months to 2025-12-31$142.4k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-31, accession 0001493152-26-014158. Derived: 12-month figure less the 9-month figure.Report this figure0.2Cost of revenue, Q1 FY2026, three months to 2026-03-31$193.8k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure0.0Cost of revenue, Q2 FY2026, three months to 2026-06-30$45.3k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure
Gross profit$m2.2Gross profit, Q3 FY2023, three months to 2023-09-30$2.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-07, accession 0001493152-24-044008.Report this figure0.6Gross profit, Q4 FY2023, three months to 2023-12-31$587.3k. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-27, accession 0001641172-25-000932. Derived: 12-month figure less the 9-month figure.Report this figure0.2Gross profit, Q1 FY2024, three months to 2024-03-31$233.3k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-08, accession 0001641172-25-009257.Report this figure2.4Gross profit, Q2 FY2024, three months to 2024-06-30$2.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-14, accession 0001641172-25-024029.Report this figure0.3Gross profit, Q3 FY2024, three months to 2024-09-30$343.7k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure(0.1)Gross profit, Q4 FY2024, three months to 2024-12-31−$105.7k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001493152-26-014158. Derived: 12-month figure less the 9-month figure.Report this figure0.0Gross profit, Q1 FY2025, three months to 2025-03-31$28.7k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure0.1Gross profit, Q2 FY2025, three months to 2025-06-30$130.8k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure0.1Gross profit, Q3 FY2025, three months to 2025-09-30$119.1k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure0.1Gross profit, Q4 FY2025, three months to 2025-12-31$121.5k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001493152-26-014158. Derived: 12-month figure less the 9-month figure.Report this figure(0.0)Gross profit, Q1 FY2026, three months to 2026-03-31−$47.8k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure0.1Gross profit, Q2 FY2026, three months to 2026-06-30$120.8k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure
Research and development$m5.8Research and development, Q3 FY2023, three months to 2023-09-30$5.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001493152-24-044008.Report this figure6.2Research and development, Q4 FY2023, three months to 2023-12-31$6.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-27, accession 0001641172-25-000932. Derived: 12-month figure less the 9-month figure.Report this figure5.7Research and development, Q1 FY2024, three months to 2024-03-31$5.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001641172-25-009257.Report this figure5.6Research and development, Q2 FY2024, three months to 2024-06-30$5.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001641172-25-024029.Report this figure4.9Research and development, Q3 FY2024, three months to 2024-09-30$4.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure4.8Research and development, Q4 FY2024, three months to 2024-12-31$4.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001493152-26-014158. Derived: 12-month figure less the 9-month figure.Report this figure4.9Research and development, Q1 FY2025, three months to 2025-03-31$4.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure4.7Research and development, Q2 FY2025, three months to 2025-06-30$4.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure4.5Research and development, Q3 FY2025, three months to 2025-09-30$4.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure5.1Research and development, Q4 FY2025, three months to 2025-12-31$5.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001493152-26-014158. Derived: 12-month figure less the 9-month figure.Report this figure5.9Research and development, Q1 FY2026, three months to 2026-03-31$5.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure4.2Research and development, Q2 FY2026, three months to 2026-06-30$4.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure
Operating income$m(8.9)Operating income, Q3 FY2023, three months to 2023-09-30−$8.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001493152-24-044008.Report this figure(11.8)Operating income, Q4 FY2023, three months to 2023-12-31−$11.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-27, accession 0001641172-25-000932. Derived: 12-month figure less the 9-month figure.Report this figure(10.3)Operating income, Q1 FY2024, three months to 2024-03-31−$10.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001641172-25-009257.Report this figure(7.7)Operating income, Q2 FY2024, three months to 2024-06-30−$7.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001641172-25-024029.Report this figure(10.2)Operating income, Q3 FY2024, three months to 2024-09-30−$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure(11.9)Operating income, Q4 FY2024, three months to 2024-12-31−$11.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-014158. Derived: 12-month figure less the 9-month figure.Report this figure(8.6)Operating income, Q1 FY2025, three months to 2025-03-31−$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure(8.1)Operating income, Q2 FY2025, three months to 2025-06-30−$8.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure(7.0)Operating income, Q3 FY2025, three months to 2025-09-30−$7.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure(26.5)Operating income, Q4 FY2025, three months to 2025-12-31−$26.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-014158. Derived: 12-month figure less the 9-month figure.Report this figure(9.2)Operating income, Q1 FY2026, three months to 2026-03-31−$9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure(6.2)Operating income, Q2 FY2026, three months to 2026-06-30−$6.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m(2.1)Income tax, Q3 FY2023, three months to 2023-09-30−$2.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0001493152-24-044008.Report this figure3.8Income tax, Q4 FY2023, three months to 2023-12-31$3.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-27, accession 0001641172-25-000932. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$22.8k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0001641172-25-009257.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$20.6k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-14, accession 0001641172-25-024029.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$22.2k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure(0.0)Income tax, Q4 FY2024, three months to 2024-12-31−$8.2k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-31, accession 0001493152-26-014158. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$12.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$12.3k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure(1.2)Income tax, Q3 FY2025, three months to 2025-09-30−$1.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure(0.5)Income tax, Q4 FY2025, three months to 2025-12-31−$473.7k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-31, accession 0001493152-26-014158. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$520. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$19.2k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure
Net income$m(6.0)Net income, Q3 FY2023, three months to 2023-09-30−$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001493152-24-044008.Report this figure(14.7)Net income, Q4 FY2023, three months to 2023-12-31−$14.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-27, accession 0001641172-25-000932. Derived: 12-month figure less the 9-month figure.Report this figure(9.3)Net income, Q1 FY2024, three months to 2024-03-31−$9.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure(7.6)Net income, Q2 FY2024, three months to 2024-06-30−$7.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure(9.7)Net income, Q3 FY2024, three months to 2024-09-30−$9.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure(11.0)Net income, Q4 FY2024, three months to 2024-12-31−$11.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-014158. Derived: 12-month figure less the 9-month figure.Report this figure(7.5)Net income, Q1 FY2025, three months to 2025-03-31−$7.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure(7.7)Net income, Q2 FY2025, three months to 2025-06-30−$7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure(5.9)Net income, Q3 FY2025, three months to 2025-09-30−$5.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure(25.7)Net income, Q4 FY2025, three months to 2025-12-31−$25.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-014158. Derived: 12-month figure less the 9-month figure.Report this figure(9.1)Net income, Q1 FY2026, three months to 2026-03-31−$9.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure(6.3)Net income, Q2 FY2026, three months to 2026-06-30−$6.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure
Diluted EPS$ per share(0.20)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001493152-24-044008.Report this figurenot reported(0.31)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0001641172-25-009257.Report this figure(0.25)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001641172-25-024029.Report this figure(0.32)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figurenot reported(7.05)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$7.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure(7.00)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$7.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure(0.16)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figurenot reported(4.06)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$4.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure(1.46)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure
Basic EPS$ per share(0.20)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001493152-24-044008.Report this figurenot reported(0.31)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001641172-25-009257.Report this figure(0.25)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001641172-25-024029.Report this figure(0.32)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figurenot reported(7.05)Basic EPS, Q1 FY2025, three months to 2025-03-31−$7.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure(7.00)Basic EPS, Q2 FY2025, three months to 2025-06-30−$7.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure(0.16)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figurenot reported(4.06)Basic EPS, Q1 FY2026, three months to 2026-03-31−$4.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure(1.46)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure

Balance sheet

Cash and equivalents$3.6m, Q2 FY2026
Shareholders' equity$12.7m, Q2 FY2026
Co-Diagnostics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m10.2Cash and equivalents, Q3 FY2023, at 2023-09-30$10.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0001493152-23-040050.Report this figure14.9Cash and equivalents, FY2023, at 2023-12-31$14.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure23.1Cash and equivalents, Q1 FY2024, at 2024-03-31$23.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0001493152-24-018424.Report this figure13.9Cash and equivalents, Q2 FY2024, at 2024-06-30$13.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001493152-24-030758.Report this figure10.8Cash and equivalents, Q3 FY2024, at 2024-09-30$10.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001493152-24-044008.Report this figure2.9Cash and equivalents, FY2024, at 2024-12-31$2.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure1.9Cash and equivalents, Q1 FY2025, at 2025-03-31$1.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001641172-25-009257.Report this figure11.1Cash and equivalents, Q2 FY2025, at 2025-06-30$11.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001641172-25-024029.Report this figure11.4Cash and equivalents, Q3 FY2025, at 2025-09-30$11.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure11.9Cash and equivalents, FY2025, at 2025-12-31$11.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure8.2Cash and equivalents, Q1 FY2026, at 2026-03-31$8.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure3.6Cash and equivalents, Q2 FY2026, at 2026-06-30$3.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure
Current assets$m71.3Current assets, Q3 FY2023, at 2023-09-30$71.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001493152-23-040050.Report this figure62.1Current assets, FY2023, at 2023-12-31$62.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure53.7Current assets, Q1 FY2024, at 2024-03-31$53.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001493152-24-018424.Report this figure48.2Current assets, Q2 FY2024, at 2024-06-30$48.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001493152-24-030758.Report this figure40.1Current assets, Q3 FY2024, at 2024-09-30$40.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001493152-24-044008.Report this figure32.3Current assets, FY2024, at 2024-12-31$32.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure23.8Current assets, Q1 FY2025, at 2025-03-31$23.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001641172-25-009257.Report this figure15.3Current assets, Q2 FY2025, at 2025-06-30$15.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001641172-25-024029.Report this figure14.1Current assets, Q3 FY2025, at 2025-09-30$14.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure13.7Current assets, FY2025, at 2025-12-31$13.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure9.8Current assets, Q1 FY2026, at 2026-03-31$9.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure5.2Current assets, Q2 FY2026, at 2026-06-30$5.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure
Total assets$m109Total assets, Q3 FY2023, at 2023-09-30$108.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001493152-23-040050.Report this figure95.3Total assets, FY2023, at 2023-12-31$95.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure86.7Total assets, Q1 FY2024, at 2024-03-31$86.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001493152-24-018424.Report this figure80.7Total assets, Q2 FY2024, at 2024-06-30$80.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001493152-24-030758.Report this figure72.4Total assets, Q3 FY2024, at 2024-09-30$72.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001493152-24-044008.Report this figure63.6Total assets, FY2024, at 2024-12-31$63.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure55.1Total assets, Q1 FY2025, at 2025-03-31$55.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001641172-25-009257.Report this figure46.5Total assets, Q2 FY2025, at 2025-06-30$46.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001641172-25-024029.Report this figure44.7Total assets, Q3 FY2025, at 2025-09-30$44.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure24.7Total assets, FY2025, at 2025-12-31$24.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure21.5Total assets, Q1 FY2026, at 2026-03-31$21.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure16.6Total assets, Q2 FY2026, at 2026-06-30$16.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure
Current liabilities$m5.1Current liabilities, Q3 FY2023, at 2023-09-30$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001493152-23-040050.Report this figure5.7Current liabilities, FY2023, at 2023-12-31$5.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure5.3Current liabilities, Q1 FY2024, at 2024-03-31$5.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001493152-24-018424.Report this figure5.3Current liabilities, Q2 FY2024, at 2024-06-30$5.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001493152-24-030758.Report this figure5.8Current liabilities, Q3 FY2024, at 2024-09-30$5.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001493152-24-044008.Report this figure7.3Current liabilities, FY2024, at 2024-12-31$7.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure5.4Current liabilities, Q1 FY2025, at 2025-03-31$5.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001641172-25-009257.Report this figure3.7Current liabilities, Q2 FY2025, at 2025-06-30$3.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001641172-25-024029.Report this figure3.7Current liabilities, Q3 FY2025, at 2025-09-30$3.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure3.5Current liabilities, FY2025, at 2025-12-31$3.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure4.3Current liabilities, Q1 FY2026, at 2026-03-31$4.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure2.9Current liabilities, Q2 FY2026, at 2026-06-30$2.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure
Total liabilities$m9.2Total liabilities, Q3 FY2023, at 2023-09-30$9.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001493152-23-040050.Report this figure9.3Total liabilities, FY2023, at 2023-12-31$9.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure8.3Total liabilities, Q1 FY2024, at 2024-03-31$8.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001493152-24-018424.Report this figure8.3Total liabilities, Q2 FY2024, at 2024-06-30$8.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001493152-24-030758.Report this figure8.6Total liabilities, Q3 FY2024, at 2024-09-30$8.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001493152-24-044008.Report this figure9.7Total liabilities, FY2024, at 2024-12-31$9.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure7.2Total liabilities, Q1 FY2025, at 2025-03-31$7.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001641172-25-009257.Report this figure5.3Total liabilities, Q2 FY2025, at 2025-06-30$5.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001641172-25-024029.Report this figure4.9Total liabilities, Q3 FY2025, at 2025-09-30$4.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure4.1Total liabilities, FY2025, at 2025-12-31$4.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure5.5Total liabilities, Q1 FY2026, at 2026-03-31$5.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure3.9Total liabilities, Q2 FY2026, at 2026-06-30$3.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m99.5Shareholders' equity, Q3 FY2023, at 2023-09-30$99.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001493152-24-044008.Report this figure85.6Shareholders' equity, FY2023, at 2023-12-31$85.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure78.4Shareholders' equity, Q1 FY2024, at 2024-03-31$78.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure72.4Shareholders' equity, Q2 FY2024, at 2024-06-30$72.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure63.8Shareholders' equity, Q3 FY2024, at 2024-09-30$63.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure53.9Shareholders' equity, FY2024, at 2024-12-31$53.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure47.5Shareholders' equity, Q1 FY2025, at 2025-03-31$47.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure40.7Shareholders' equity, Q2 FY2025, at 2025-06-30$40.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure39.8Shareholders' equity, Q3 FY2025, at 2025-09-30$39.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure20.6Shareholders' equity, FY2025, at 2025-12-31$20.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure16.0Shareholders' equity, Q1 FY2026, at 2026-03-31$16.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure12.7Shareholders' equity, Q2 FY2026, at 2026-06-30$12.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure

Cash flow

Operating cash flow−$7.2m, Q2 FY2026
Capital expenditure$18.3k, Q2 FY2026
Share repurchases$159.7k, Q4 FY2023
Co-Diagnostics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(5,765)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$5.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001493152-24-044008. Derived: 9-month figure less the 6-month figure.Report this figure(4,779)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$4.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-27, accession 0001641172-25-000932. Derived: 12-month figure less the 9-month figure.Report this figure(8,490)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$8.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001641172-25-009257.Report this figure(5,204)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$5.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001641172-25-024029. Derived: 6-month figure less the 3-month figure.Report this figure(7,230)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001493152-25-022300. Derived: 9-month figure less the 6-month figure.Report this figure(8,231)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$8.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001493152-26-014158. Derived: 12-month figure less the 9-month figure.Report this figure(8,745)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$8.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure(8,288)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$8.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001493152-26-037762. Derived: 6-month figure less the 3-month figure.Report this figure(5,905)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$5.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001493152-25-022300. Derived: 9-month figure less the 6-month figure.Report this figure(6,199)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$6.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001493152-26-014158. Derived: 12-month figure less the 9-month figure.Report this figure(7,846)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$7.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure(7,153)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001493152-26-037762. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k237Capital expenditure, Q3 FY2023, three months to 2023-09-30$236.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001493152-24-044008. Derived: 9-month figure less the 6-month figure.Report this figure465Capital expenditure, Q4 FY2023, three months to 2023-12-31$464.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-27, accession 0001641172-25-000932. Derived: 12-month figure less the 9-month figure.Report this figure402Capital expenditure, Q1 FY2024, three months to 2024-03-31$402.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0001641172-25-009257.Report this figure98.6Capital expenditure, Q2 FY2024, three months to 2024-06-30$98.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0001641172-25-024029. Derived: 6-month figure less the 3-month figure.Report this figure174Capital expenditure, Q3 FY2024, three months to 2024-09-30$174.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001493152-25-022300. Derived: 9-month figure less the 6-month figure.Report this figure73.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$73.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001493152-26-014158. Derived: 12-month figure less the 9-month figure.Report this figure91.9Capital expenditure, Q1 FY2025, three months to 2025-03-31$91.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure401Capital expenditure, Q2 FY2025, three months to 2025-06-30$401.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001493152-26-037762. Derived: 6-month figure less the 3-month figure.Report this figure75.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$75.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001493152-25-022300. Derived: 9-month figure less the 6-month figure.Report this figure132Capital expenditure, Q4 FY2025, three months to 2025-12-31$132.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001493152-26-014158. Derived: 12-month figure less the 9-month figure.Report this figure142Capital expenditure, Q1 FY2026, three months to 2026-03-31$142.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure18.3Capital expenditure, Q2 FY2026, three months to 2026-06-30$18.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001493152-26-037762. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$k166Share repurchases, Q3 FY2023, three months to 2023-09-30$166.3k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-07, accession 0001493152-24-044008. Derived: 9-month figure less the 6-month figure.Report this figure160Share repurchases, Q4 FY2023, three months to 2023-12-31$159.7k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-27, accession 0001641172-25-000932. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)4.31m, Q2 FY2026
Co-Diagnostics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares31.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3031,321,368 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0001493152-23-040050.Report this figure29.5Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3129,483,540 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001493152-24-018424.Report this figure29.1Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3029,088,159 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001493152-24-030758.Report this figure29.4Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3029,361,300 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001493152-24-044008.Report this figure29.8Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3129,842,874 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0001641172-25-009257.Report this figure30.1Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3030,124,696 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001641172-25-024029.Report this figure30.5Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3030,494,206 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure1.1Diluted shares (weighted), Q1 FY2025, three months to 2025-03-311,068,299 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure1.1Diluted shares (weighted), Q2 FY2025, three months to 2025-06-301,103,614 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure37.9Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3037,890,923 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001493152-25-022300.Report this figure2.3Diluted shares (weighted), Q1 FY2026, three months to 2026-03-312,253,474 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001493152-26-023085.Report this figure4.3Diluted shares (weighted), Q2 FY2026, three months to 2026-06-304,309,997 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure

Shares outstanding: 6.25mShares outstanding, period not labelled, at 2026-08-116,252,319 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.